Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level.
Realistic scenarios for low-level exposure to nerve agents will often involve exposures over several hours to extremely low doses of agent. In order to expose animals to the lowest controllable concentrations of agent and to increase exposure times until a lowest observable effect level (LOEL) becomes measurable, a validated system was developed for exposing conscious animals to 0.05-1.0 microg/m(3) (8-160 ppt) of sarin and other nerve agents. Based on cold trapping of sarin from the exposure air, the concentration could be measured semicontinuously, at 4-min time intervals by means of gas chromatography. We found that the LOEL upon a 5-h whole body exposure of guinea pigs and marmosets to sarin vapor corresponds with the measurement of an internal dose by means of fluoride-induced regeneration of sarin from phosphylated binding sites in plasma, mostly BuChE. For guinea pigs the LOEL was observed at Ct = 0.010 +/- 0.002 mg/min/m(3), whereas a Ct of 0.04 +/- 0.01 mg/min/m(3) was established for the LOEL in marmosets. These levels are several orders of magnitude lower than those based on classical measurement of depressed cholinesterase activities. At low exposure levels of guinea pigs and marmosets (< or =1 microg/m(3)), a reasonable linearity was observed between exposure dose and internal dose. The data were addressed in the light of the recently recommended occupational exposure limits to sarin for workers without respiratory protection, which suggests that the exposure limits should be reconsidered if the slightest inhibition of cholinesterases should be prevented.
Van Helden
Herman P M
HP
Division of Chemical and Biological Protection, TNO Prins Maurits Laboratory, P.O. Box 45, 2280 AA, Rijswijk, The Netherlands. helden@pml.tno.nl
Trap
Henk C
HC
Oostdijk
John P
JP
Kuijpers
Willem C
WC
Langenberg
Jan P
JP
Benschop
Hendrik P
HP
D000818:Animals; D001273:Atmosphere Exposure Chambers; D002144:Callithrix; D004305:Dose-Response Relationship, Drug; D005260:Female; D005740:Gases / Q000008:administration & dosage* / Q000032:analysis / Q000097:blood; D006168:Guinea Pigs; D008297:Male; D019055:No-Observed-Adverse-Effect Level; D012524:Sarin / Q000008:administration & dosage* / Q000032:analysis / Q000097:blood; D020711:Threshold Limit Values; D014835:Volatilization
D005740:Gases; D012524:Sarin